Application of machine learning in combination with mechanistic modeling to predict plasma exposure of small molecules
Prediction of a new molecule’s exposure in plasma is a critical first step toward understanding its efficacy/toxicity profile and concluding whether it is a possible first-in-class, best-in-class candidate. For this prediction, traditional pharmacometrics use a variety of scaling methods that are he...
Main Authors: | Panteleimon D. Mavroudis, Donato Teutonico, Alexandra Abos, Nikhil Pillai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Systems Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsysb.2023.1180948/full |
Similar Items
-
A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution
by: Radwan Ansaar, et al.
Published: (2023-04-01) -
Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester
by: Babajide Shenkoya, et al.
Published: (2021-09-01) -
Computational Approaches in Preclinical Studies on Drug Discovery and Development
by: Fengxu Wu, et al.
Published: (2020-09-01) -
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021-06-01) -
Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine
by: Lara Marques, et al.
Published: (2023-05-01)